Fei Peng

Direttore Finanziario/CFO presso Beijing Biostar Pharmaceuticals Co. Ltd.

50 anni

Consumer Services

Health Technology

Profilo

Fei Peng is currently the Chief Financial Officer at Beijing Biostar Pharmaceuticals Co. Ltd.
He graduated from Southwestern University of Finance & Economics with an undergraduate degree in 2006.

Posizioni attive di Fei Peng

Società	Posizione	Inizio
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Direttore Finanziario/CFO	07/03/2022

Tutte le posizioni attive di Fei Peng

Formazione di Fei Peng

Southwestern University of Finance & Economics

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Fei Peng

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Health Technology